Histologic patterns of liver injury induced by anti-PD-1 therapy
{{output}}
Background: Nivolumab and pembrolizumab-two monoclonal antibodies that block human programmed cell death-1 (PD-1)-have been successfully used to treat patients with multiple advanced malignancies. The histologic patterns of hepat... ...
